MDA — Medapp SA Income Statement
0.000.00%
- PLN26.89m
- PLN31.07m
- PLN7.20m
Annual income statement for Medapp SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.
2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | PAS | PAS | PAS | PAS | PAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.02 | 12.7 | 6.73 | 5.09 | 7.2 |
| Cost of Revenue | |||||
| Gross Profit | 5.47 | 10.9 | 5.23 | 3.88 | 5.36 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 3.91 | 8.29 | 5.41 | 6.1 | 4.73 |
| Operating Profit | 2.12 | 4.42 | 1.33 | -1.01 | 2.47 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1.87 | 4.42 | 1.25 | -1.22 | 2.33 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1.92 | 4.12 | 0.658 | -1.51 | 2.11 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 1.92 | 4.12 | 0.658 | -1.51 | 2.04 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1.92 | 4.12 | 0.658 | -1.51 | 2.04 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.01 | 0.018 | 0.003 | -0.006 | 0.008 |
| Dividends per Share |